Chicago Equity Partners’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$908K Sell
31,535
-80,901
-72% -$2.12M 0.09% 300
2019
Q4
$2.64M Buy
112,436
+61,311
+120% +$1.37M 0.15% 196
2019
Q3
$921K Hold
51,125
0.04% 524
2019
Q2
$801K Hold
51,125
0.04% 581
2019
Q1
$1.17M Buy
51,125
+28,675
+128% +$647K 0.05% 472
2018
Q4
$522K Buy
+22,450
New +$599K 0.02% 631
2018
Q2
Sell
-31,035
Closed -$1.3M 878
2018
Q1
$1.3M Buy
31,035
+11,445
+58% +$528K 0.04% 451
2017
Q4
$891K Buy
19,590
+11,410
+139% +$450K 0.03% 526
2017
Q3
$271K Buy
+8,180
New +$333K 0.01% 700

Other funds holding PETS

Chicago Equity Partners's PETS Position: Q1 2020 in Review

Chicago Equity Partners reduced its PetMed Express (PETS) stake by 72% in Q1 2020, selling an estimated $2.12M and leaving 31,535 shares worth $908K. The position accounts for 0.09% of the portfolio, ranked #300.

Chicago Equity Partners first reported a position in PETS in Q3 2017 and has held it in 9 quarters since. The position peaked at $2.64M in Q4 2019. 202 funds tracked by Wall St. Rank hold PETS as of Q1 2020.

  • Chicago Equity Partners held 31,535 shares of PetMed Express worth $908K as of Q1 2020.
  • Chicago Equity Partners sold 80,901 PetMed Express shares in Q1 2020, an estimated $2.12M.
  • PetMed Express made up 0.09% of Chicago Equity Partners's portfolio in Q1 2020, its #300 holding.
  • Chicago Equity Partners first reported a position in PetMed Express in Q3 2017 and has held it in 9 quarters since.
  • Chicago Equity Partners's PetMed Express position peaked at $2.64M in Q4 2019.
  • 202 funds tracked by Wall St. Rank held PetMed Express as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.